These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21041328)

  • 1. Treating multiple sclerosis with information.
    Heesen C
    Mult Scler; 2010 Nov; 16(11):1302. PubMed ID: 21041328
    [No Abstract]   [Full Text] [Related]  

  • 2. An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care.
    Solari A; Martinelli V; Trojano M; Lugaresi A; Granella F; Giordano A; Messmer Uccelli M; D'Alessandro R; Pucci E; Confalonieri P; Borreani C;
    Mult Scler; 2010 Nov; 16(11):1393-405. PubMed ID: 20858692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informed consent: practices and views of investigators in a multinational clinical trial.
    Sabik L; Pace CA; Forster-Gertner HP; Wendler D; Bebchuk JD; Tavel JA; McNay LA; Killen J; Emanuel EJ; Grady C
    IRB; 2005; 27(5):13-8. PubMed ID: 16425476
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
    Sandberg-Wollheim M; Hommes OR; Hughes RA; Paty DW; Abdul-Ahad AK
    Mult Scler; 1995; 1 Suppl 1():S48-50. PubMed ID: 9345399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Symptomatic therapy of multiple sclerosis].
    Henze T
    Nervenarzt; 2004 Aug; 75 Suppl 1():2-39. PubMed ID: 15480526
    [No Abstract]   [Full Text] [Related]  

  • 6. [Multiple sclerosis--disclosing the diagnosis. Attitude of patients: when? How? Disclose at all?].
    Hirschmann J; Zimmermann CW
    Fortschr Neurol Psychiatr; 1987 Sep; 55(9):263-72. PubMed ID: 3666652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trial.
    Polman CH; Dahlke F; Thompson AJ; Ghazi M; Kappos L; Miltenburger C; Pozilli C
    Mult Scler; 1995; 1 Suppl 1():S51-4. PubMed ID: 9345400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [MS Therapy Consensus Group. Immunomodulating staged therapy of multiple sclerosis].
    Nervenarzt; 1999 Apr; 70(4):371-86. PubMed ID: 10355003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healing the mind: meditation and multiple sclerosis.
    Tavee J; Stone L
    Neurology; 2010 Sep; 75(13):1130-1. PubMed ID: 20876465
    [No Abstract]   [Full Text] [Related]  

  • 10. No shortcuts to outcome in MS clinical trials?
    Koch-Henriksen N
    Neurology; 2009 Feb; 72(8):686-7. PubMed ID: 19237696
    [No Abstract]   [Full Text] [Related]  

  • 11. [When and how should the diagnosis of multiple sclerosis be told to the patient--ethical dilemmas].
    Fredrikson S
    Lakartidningen; 1989 Nov; 86(45):3909-10. PubMed ID: 2811543
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interferon-beta treatment of progressive disseminated sclerosis. Is it possibly without effect?].
    Foldspang A
    Ugeskr Laeger; 1999 Aug; 161(31):4418-21. PubMed ID: 10487112
    [No Abstract]   [Full Text] [Related]  

  • 13. Is functional MRI feasible for multi-center studies on multiple sclerosis?
    Zivadinov R; Cox JL
    Eur J Neurol; 2008 Feb; 15(2):109-10. PubMed ID: 18217879
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis.
    Weiner HL; Dau PC; Khatri BO; Petajan J; Birnbaum G; McQuillen MP; Fosburg MT; Feldstein M; Orav J
    Prog Clin Biol Res; 1990; 337():283. PubMed ID: 2162062
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized controlled trial of a health promotion education programme for people with multiple sclerosis.
    Ennis M; Thain J; Boggild M; Baker GA; Young CA
    Clin Rehabil; 2006 Sep; 20(9):783-92. PubMed ID: 17005502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Knowledge about "morning-after pill" should be spread to all women. Comments on meta-analysis of postcoital contraception].
    Danielsson KG; Bygdeman M; Marions L
    Lakartidningen; 2000 Dec; 97(50):5892-5. PubMed ID: 11188530
    [No Abstract]   [Full Text] [Related]  

  • 17. [Practical problems of multiple sclerosis. Information and advice for the MS-patient].
    Bauer HJ
    Schwest Rev; 1979 Sep; 17(9):7-9. PubMed ID: 258843
    [No Abstract]   [Full Text] [Related]  

  • 18. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis. Treatment options, advances offer new hope.
    Mayo Clin Womens Healthsource; 2010 Jun; 14(6):1-2. PubMed ID: 20436384
    [No Abstract]   [Full Text] [Related]  

  • 20. Expanded clinical trials of treatments for multiple sclerosis. The Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis of The National Multiple Sclerosis Society.
    Whitaker JN
    Ann Neurol; 1993 Dec; 34(6):755-6. PubMed ID: 8250523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.